StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.82+0.02 (+0.10%)

Close on Nov 18, 2026Market cap $936.43MP/E –Yield –

Silence Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Silence Therapeutics's price to sales ratio was 388.5× on May 29, 2026, against 4.0× a year earlier. Over the last 3 years it ranged from 3.1× to 459.7×, with a median of 12.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026May 29, 2026388.5×+377.3
2025Dec 31, 202511.1×+2.5
2024Dec 31, 20248.6×−20.2
2023Dec 29, 202328.8×–

More Silence Therapeutics figures

See a number that looks wrong?